Ideaya Biosciences Inc (IDYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 112,825 | 84,378 | 157,018 | 68,632 | 92,046 |
| Marketable Securities | 526,563 | 591,941 | 368,096 | 296,197 | 154,724 |
| Receivables | N/A | N/A | 18 | 211 | 1,103 |
| Other current assets | 5,973 | 0 | 0 | 0 | 0 |
| TOTAL | $666,727 | $689,713 | $532,632 | $370,454 | $250,996 |
| Non-Current Assets | |||||
| PPE Net | 8,217 | 8,966 | 6,164 | 6,509 | 4,763 |
| Investments And Advances | 410,297 | 405,832 | 107,492 | 8,317 | 121,293 |
| Other Non-Current Assets | 24,083 | 19,580 | 3,028 | 2,689 | 4,295 |
| TOTAL | $442,597 | $434,378 | $116,684 | $17,515 | $130,351 |
| Total Assets | $1,109,324 | $1,124,091 | $649,316 | $387,969 | $381,347 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,584 | 15,421 | 6,598 | 4,280 | 2,100 |
| Accrued Expenses | 40,892 | 30,352 | 18,756 | 16,999 | 12,320 |
| Other current liabilities | N/A | N/A | N/A | 8,568 | 29,040 |
| TOTAL | $58,815 | $46,071 | $27,101 | $31,718 | $45,159 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 27,575 | 18,873 | 1,125 | 6,796 | 34,674 |
| TOTAL | $27,575 | $18,873 | $1,125 | $6,796 | $34,674 |
| Total Liabilities | $86,390 | $64,944 | $28,226 | $38,514 | $79,833 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 87,814 | 87,537 | 74,560 | 48,387 | 38,627 |
| Common Shares | 9 | 9 | 7 | 5 | 4 |
| Retained earnings | -736,539 | -622,841 | -348,364 | -235,403 | -176,748 |
| Other shareholders' equity | 2,267 | 812 | 562 | -2,871 | -712 |
| TOTAL | $1,022,934 | $1,059,147 | $621,090 | $349,455 | $301,514 |
| Total Liabilities And Equity | $1,109,324 | $1,124,091 | $649,316 | $387,969 | $381,347 |